Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Campone, Mario"'
Autor:
Goetz MP; Mayo Clinic, Rochester, Minnesota., Hamilton EP; Sarah Cannon Research Institute, Tennessee Oncology PLCC, Nashville, Tennessee., Campone M; Institut de Cancerologie de l'Ouest, Angers Cedex, France., Hurvitz SA; University of California, Los Angeles, California., Cortes J; Oncology Department, International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Department of Medicine, Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Madrid, Spain., Johnston S; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Llombart-Cussac A; Hospital Arnau Vilanova, Valencia, Spain., Kaufman PA; University of Vermont Medical Center, Burlington, Vermont., Toi M; Kyoto University, Kyoto, Japan., Jerusalem G; CHU Liege and Liege University, Liege, Belgium., Graham H; Eli Lilly and Company, Indianapolis, Indiana., Wang H; Eli Lilly and Company, Indianapolis, Indiana., Jansen VM; Eli Lilly and Company, Indianapolis, Indiana., Litchfield LM; Eli Lilly and Company, Indianapolis, Indiana., Martin M; Instiuto de Investigacion Santaria Gregorio Maranon, Universidad Complutense, CIBERONC, Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2233-2244.
Autor:
Kessler T; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Schrimpf D; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, DKTK, DKFZ, Heidelberg, Germany., Doerner L; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Hai L; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Kaulen LD; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Ito J; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., van den Bent M; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Taphoorn M; Haaglanden Medical Center, The Hague, the Netherlands.; Leiden University Medical Center, Leiden, the Netherlands., Brandes AA; The Medical Oncology Department, Azienda Unità Sanitaria Locale di Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy., Idbaih A; Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neurologie 2-Mazarin, Paris, France., Dômont J; Institut Gustave Roussy, Villejuif, France., Clement PM; Leuven Cancer Institute-KU Leuven, Leuven, Belgium., Campone M; Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau, Saint-Herblain, France., Bendszus M; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany., von Deimling A; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, DKTK, DKFZ, Heidelberg, Germany., Sahm F; Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, DKTK, DKFZ, Heidelberg, Germany., Platten M; Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, DKTK, DKFZ, Heidelberg, Germany.; Department of Neurology, Medical Faculty Mannheim, MCTN, Heidelberg University, Mannheim, Germany., Wick W; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Wick A; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Oct 02; Vol. 29 (19), pp. 3892-3900.
Autor:
Kuemmel S; Interdisciplinary Breast Unit, Kliniken Essen-Mitte, Essen, Germany. s.kuemmel@kem-med.com., Campone M; Institut de Cancérologie de l'Ouest-Centre René Gauducheau, St Herblain, France., Loirat D; Medical Oncology Department and D3i, Institut Curie, Paris, France., Lopez RL; Clinical University Hospital & Health Research Institute of Santiago de Compostela-CIBERONC, Santiago de Compostela, Spain., Beck JT; Highlands Oncology Group, Fayetteville, Massachusetts., De Laurentiis M; Istituto Nazionale dei Tumori IRCCS 'Fondazione Pascale', Napoli, Italy., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Kwong A; Queen Mary Hospital, The University of Hong Kong, Hong Kong., Steger GG; Department of Internal Medicine I, Division of Oncology and Gaston H. Glock Research Center, Medical University of Vienna, Vienna, Austria., Adelantado EZ; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Duhoux FP; King Albert II Cancer Institute, Cliniques universitaires Saint-Luc, UCLouvain, Brussels, Belgium., Greil R; Paracelsus Medical University, Salzburg Cancer Research Institute-CCCIT and Cancer Cluster Salzburg, Salzburg, Austria., Kuter I; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Lu YS; National Taiwan University Hospital, Taipei, Taiwan., Tibau A; Oncology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain., Özgüroğlu M; Istanbul University - Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey., Scholz CW; Vivantes Klinikum Am Urban, Berlin, Germany., Singer CF; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Vega E; CIOCC-Grupo Hospitalario de Madrid, Madrid, Spain., Wimberger P; Carl Gustav Carus University, TU Dresden, Dresden, Germany., Zamagni C; Osp.di bologna, Bologna, Italy., Couillebault XM; Novartis Pharma AG, Basel, Switzerland., Fan L; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Guerreiro N; Novartis Pharma AG, Basel, Switzerland., Mataraza J; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts., Sand-Dejmek J; Novartis Pharma AG, Basel, Switzerland., Chan A; Breast Cancer Research Centre-WA & Curtin University, Perth, Western Australia, Australia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jan 01; Vol. 28 (1), pp. 106-115. Date of Electronic Publication: 2021 Oct 06.
Autor:
Bardia A; Departments of Medicine and Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. bardia.aditya@mgh.harvard.edu., Modi S; Breast Medicine Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York., Oliveira M; Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Cortes J; Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain and IOB Institute of Oncology, Quirónsalud Group, Madrid and Barcelona, Spain., Campone M; Department of Oncology, Institute of Cancer Research, Pays de la Loire, France., Ma B; Department of Clinical Oncology, Phase 1 Clinical Trial Center, The Chinese University of Hong Kong, Hong Kong, China., Dirix L; Oncology Centre, Sint Augustinus Hospital, Antwerp, Belgium., Weise A; Department of Hematology & Oncology, Karmanos Cancer Institute, Detroit, Michigan., Hewes B; Medical Department, Repertoire Immune Medicines, Cambridge, Massachusetts., Diaz-Padilla I; Oncology Global Development, Merck Group, Eysins, Switzerland., Han Y; Biostatistics Department, Novartis Pharmaceuticals, East Hanover, New Jersey., Deshpande P; GDO Trial Management - Oncology, Novartis Pharmaceuticals, East Hanover, New Jersey., Samant TS; Pharmacokinetic Sciences, Novartis Pharmaceuticals, East Hanover, New Jersey., Lorenc KR; Global Development, Novartis Pharmaceuticals, East Hanover, New Jersey., He W; Biostatistics Department, Novartis Pharmaceuticals, East Hanover, New Jersey., Su F; Global Development, Novartis Pharmaceuticals, East Hanover, New Jersey., Chavez-MacGregor M; Department of Breast Medical Oncology, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Dec 15; Vol. 26 (24), pp. 6417-6428. Date of Electronic Publication: 2020 Sep 30.
Autor:
Li W; Janssen Research & Development, Spring House, Pennsylvania. wli78@its.jnj.com., O'Shaughnessy J; US Oncology, Dallas, Texas., Hayes D; The University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan., Campone M; Institut de Cancérologie de l'Ouest, Nantes, France., Bondarenko I; Dnepropetrovsk Medical Academy, Municipal Clinical Hospital #4, Dnepropetrovsk, Ukraine., Zbarskaya I; Leningrad Regional Oncology Dispensary, Saint Petersburg, Russia., Brain E; Hôpital René Huguenin, Saint-Cloud, France., Stenina M; N.N. Blokhin Cancer Research Center, Moscow, Russia., Ivanova O; Research Institute of Oncology, Saint Petersburg, Russia., Graas MP; CHC, Liège, Belgium., Neven P; University Hospitals Leuven, Leuven, Belgium., Ricci D; Janssen Research & Development, Raritan, New Jersey., Griffin T; Janssen Research & Development, Los Angeles, California., Kheoh T; Janssen Research & Development, San Diego, California., Yu M; Janssen Research & Development, Los Angeles, California., Gormley M; Janssen Research & Development, Spring House, Pennsylvania., Martin J; Janssen Research & Development, High Wycombe, United Kingdom., Schaffer M; Janssen Research & Development, Spring House, Pennsylvania., Zelinsky K; Janssen Research & Development, Spring House, Pennsylvania., De Porre P; Janssen Research & Development, Beerse, Belgium., Johnston SR; The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Dec 15; Vol. 22 (24), pp. 6002-6009. Date of Electronic Publication: 2016 Jun 07.
Autor:
Wick W; Neurology Clinic, University of Heidelberg, Heidelberg, Germany. Clinical Cooperation Unit (CCU) Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. wolfgang.wick@med.uni-heidelberg.de., Gorlia T; European Organisation for Research and Treatment of Cancer (EORTC), Lausanne, Switzerland., Bady P; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. Neuroscience Research Center, University Hospital Lausanne (CHUV), Lausanne, Switzerland., Platten M; Neurology Clinic, University of Heidelberg, Heidelberg, Germany. CCU Brain Tumor Immunology, DKFZ, Heidelberg, Germany., van den Bent MJ; Department of Neurology/Neuro-Oncology, Erasmus MC - Cancer Institute, Rotterdam, the Netherlands., Taphoorn MJ; Neuro-oncology Unit, MC Haaglanden, The Hague, the Netherlands., Steuve J; European Organisation for Research and Treatment of Cancer (EORTC), Lausanne, Switzerland., Brandes AA; Department of Medical Oncology, Ospedale Bellaria, Bologna, Italy., Hamou MF; Neuroscience Research Center, University Hospital Lausanne (CHUV), Lausanne, Switzerland. Department of Neurosurgery, CHUV, Lausanne, Switzerland., Wick A; Neurology Clinic, University of Heidelberg, Heidelberg, Germany., Kosch M; Pfizer, Berlin, Germany., Weller M; Department of Neurology, University Hospital and University of Zurich, Switzerland., Stupp R; Department of Neurosurgery, CHUV, Lausanne, Switzerland., Roth P; Department of Neurology, University Hospital and University of Zurich, Switzerland., Golfinopoulos V; European Organisation for Research and Treatment of Cancer (EORTC), Lausanne, Switzerland., Frenel JS; 1-Institut de Cancérologie de l'OUEST, Saint Herblain-Nantes Cedex, France., Campone M; 1-Institut de Cancérologie de l'OUEST, Saint Herblain-Nantes Cedex, France., Ricard D; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin, UMR8257 MD4 Cognac G, CNRS, Service de Santé des Armées, Université Paris Descartes, Paris, France., Marosi C; General Hospital AKH, Medical University Vienna, Austria., Villa S; Institut Catala d'Oncologia (ICO), Hospital Germans Trias Pujol, Badalona, Barcelona, Spain., Weyerbrock A; Department of Neurosurgery, Medical Center, University of Freiburg, Germany., Hopkins K; University Hospitals Bristol NHS Foundation Trust - Bristol Haematology and Oncology Centre, Bristol, United Kingdom., Homicsko K; Department of Oncology, CHUV, Lausanne, Switzerland., Lhermitte B; Institute of Pathology, CHUV, Lausanne, Switzerland., Pesce G; Department of Radio-oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Hegi ME; Neuroscience Research Center, University Hospital Lausanne (CHUV), Lausanne, Switzerland. Department of Neurosurgery, CHUV, Lausanne, Switzerland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Oct 01; Vol. 22 (19), pp. 4797-4806. Date of Electronic Publication: 2016 May 03.
Autor:
Pierga JY; Institut Curie, Paris, France. Université Paris Descartes, Paris, France., Petit T; Centre Paul Strauss, Strasbourg, France., Lévy C; Centre François Baclesse, Caen, France., Ferrero JM; Centre Antoine Lacassagne, Nice, France., Campone M; Institut de Cancérologie de l'Ouest-René Gauducheau, Saint Herblain, France., Gligorov J; APHP Tenon, Alliance pour la Recherche en Cancérologie, Paris, France. Institut Universitaire de Cancérologie-Paris VI, Sorbonne Université, Paris, France., Lerebours F; Institut Curie Hôpital René Huguenin, Saint-Cloud, France., Roché H; Institut Claudius Regaud, Toulouse, France., Bachelot T; Centre Léon-Bérard, Lyon, France., Charafe-Jauffret E; Institut Paoli-Calmettes, Marseille, France. Aix-Marseille University, Marseille, France., Bonneterre J; Institut Oscar Lambret, Lille, France., Hernandez J; Roche, Boulogne-Billancourt, France., Bidard FC; Institut Curie, Paris, France., Viens P; Institut Paoli-Calmettes, Marseille, France. Aix-Marseille University, Marseille, France. viensp@ipc.unicancer.fr.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Mar 15; Vol. 21 (6), pp. 1298-304. Date of Electronic Publication: 2014 Dec 23.
Autor:
André F; Department of Medical Oncology, INSERM Unit U981, Paris Sud University, Institut Gustave-Roussy, Villejuif, France. fabrice.andre@igr.fr, Bachelot T, Campone M, Dalenc F, Perez-Garcia JM, Hurvitz SA, Turner N, Rugo H, Smith JW, Deudon S, Shi M, Zhang Y, Kay A, Porta DG, Yovine A, Baselga J
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Jul 01; Vol. 19 (13), pp. 3693-702. Date of Electronic Publication: 2013 May 08.
Autor:
Mayer EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. Erica_Mayer@dfci.harvard.edu, Baurain JF, Sparano J, Strauss L, Campone M, Fumoleau P, Rugo H, Awada A, Sy O, Llombart-Cussac A
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2011 Nov 01; Vol. 17 (21), pp. 6897-904. Date of Electronic Publication: 2011 Sep 08.
Autor:
Schmitt A; Institut Claudius-Regaud and EA3035 University of Toulouse, Toulouse, France., Gladieff L, Lansiaux A, Bobin-Dubigeon C, Etienne-Grimaldi MC, Boisdron-Celle M, Serre-Debauvais F, Pinguet F, Floquet A, Billaud E, Le Guellec C, Penel N, Campone M, Largillier R, Capitain O, Fabbro M, Houede N, Medioni J, Bougnoux P, Lochon I, Chatelut E
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2009 May 15; Vol. 15 (10), pp. 3633-9. Date of Electronic Publication: 2009 Apr 28.